AstraZeneca, the global pharmaceutical giant that has been spearheading the vaccine war against the COVID-19 coronavirus, has signed to move its headquarters to the King's Cross Central development in London.
AstraZeneca, the global pharmaceutical giant that has been spearheading the vaccine war against the COVID-19 coronavirus, has signed to move its headquarters to the King's Cross Central development in London.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In